Genesis Therapeutics Stock
HealthTechLooking to sell Genesis Therapeutics stock or options?
Genesis Therapeutics is a developer of a computational platform focused on discovering small-molecule drugs. The company utilizes its proprietary molecular AI technology to advance the discovery and development of innovative drugs aimed at treating patients with severe and debilitating diseases. This approach empowers the medical community to enhance and optimize clinical outcomes for patients.
Jeff Rothschild, Ulu Ventures, Baker Brothers Investments, Society Health, BlackRock, Rock Springs Capital, NVentures (Santa Clara), Harpoon Ventures, JAZZ Venture Partners, Harpoon VC, Open Field Capital, CLF Partners, T. Rowe Price Group, Andreessen Horowitz, Alumni Ventures, Mark Leslie, Felicis, Fidelity Management & Research, Propagator Ventures, Mana Ventures, Radical Ventures, Eli Lilly and Company, Menlo Ventures.